Tag: Cansino trials argentina
RIO DE JANEIRO, BRAZIL - CanSino Biologics Inc will start testing its coronavirus vaccine candidate in late-stage human trials in Argentina and Chile, the co-founder of the Chinese pharmaceutical company said on Saturday, November 21st.
The candidate Ad5-nCoV, which goes...